Sensitive

Urine 3-hydroxydodecanedioate* levels in chronic kidney disease

SLC17A1 · rs1165215

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−34, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 4,656 European ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.296 higher (95% confidence interval 0.25-0.34); p = 5 × 10−35.

How common The A allele had a frequency of about 53% in the people studied.

Where it sits Chromosome 6, band 6p22.2 — in the 3′ untranslated region of SLC17A1.

How common each version is

AG
Korean KRGDB
A 86.0% · G 14.0%
Korean Korea4K
A 85.7% · G 14.3%
Korean Korea1K
A 85.6% · G 14.4%
Japanese ToMMo
A 84.7% · G 15.3%
Vietnamese
A 68.1% · G 31.9%
World gnomAD
A 66.4% · G 33.6%
World 1000 Genomes
A 72.0% · G 28.0%
World TOPMed
A 67.8% · G 32.2%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

A/A Two copies of the version the research linked to Urine 3-hydroxydodecanedioate* levels in chronic kidney disease. That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Urine 3-hydroxydodecanedioate* levels in chronic kidney disease. That is a smaller link than two copies.
G/G No copy of the version the research linked to Urine 3-hydroxydodecanedioate* levels in chronic kidney disease. This is the starting point the study compared everyone against.
Source

Questions about rs1165215

What is rs1165215?

rs1165215 is a single position in the genome, in or near the SLC17A1 gene. Published research associates it with urine 3-hydroxydodecanedioate* levels in chronic kidney disease. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

Does having rs1165215 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs1165215 come from?

GWAS Catalog, Nature genetics 2023, PMID:37277652. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Urine 3-hydroxydodecanedioate* levels in chronic kidney disease (rs1165215). MyGeneLog™. https://www.mygenelog.com/variants/rs1165215

← See all variants